Changes of urotensin II in induced sputum and plasma of patients with COPD and asthma Source: Eur Respir J 2006; 28: Suppl. 50, 672s Year: 2006
Decreased VEGF concentration in lung tissue and vascular injury during ARDS Source: Eur Respir J 2005; 25: 139-146 Year: 2005
Collagen I, III and IV content in airways and lung parenchyma of COPD patients Source: Annual Congress 2010 - Proteases and the matrix Year: 2010
HGF and IL-6 in BAL fluid of interstitial lung diseases: effect on human lung fibroblasts Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008
RAGE, a marker of alveolar epithelial type I cell injury, predicts impaired alveolar fluid clearance in isolated perfused human lungs Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007
Decreased expression of TGFβ1 type II receptor in bronchial glands of smokers with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 98s Year: 2004
Effect of alveolar type II cells in acute lung injury model Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015
Increased expression of SARS-CoV-2 (Covid-19) adhesion sites on type II pneumocytes, small airway epithelium, and alveolar macrophages in smokers and patients with COPD Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021
Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs Source: Eur Respir J 2007; 29: 1105-1114 Year: 2007
Altered kinetics of TGFβ receptor II expression in pulmonary fibroblasts of COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 224s Year: 2005
The dynamics of IV-type collagen contents in BALF of patients with COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012
Reduction of denitration-like activity in COPD lung tissue Source: Eur Respir J 2004; 24: Suppl. 48, 99s Year: 2004
Role of alveolar macrophages in acute lung injury model Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury Year: 2017
PP231 – Released mediators in ex vivo 3D-model of lung fibrosis correspond to elevated serum biomarkers in IPF Source: ERS Lung Science Conference 2021 Year: 2021
Released mediators in ex vivo 3D-model of lung fibrosis correspond to elevated serum biomarkers in IPF Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis Year: 2021
Transplant of alveolar type II cells restore pulmonary surfactant in lung fibrosis Source: Annual Congress 2010 - Stem cells and growth factors in lung injury Year: 2010
Dose-response of the lectin-like domain of TNF on lung oedema and lung mechanics in isolated rat lungs subjected to LPS-induced lung injury Source: Eur Respir J 2006; 28: Suppl. 50, 348s Year: 2006
Serum levels of a MMP-12 generated type IV collagen fragment is elevated in COPD and IPF patients Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013
Relaxin potentiates ß2-adrenoceptor mediated bronchodilation in precision-cut lung slices (PCLS) from mouse models of airway inflammation and fibrosis, and in human airways Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019
Increased alveolar soluble annexin V promotes lung inflammation and fibrosis Source: Eur Respir J 2015; 46: 1417-1429 Year: 2015